Please login or register first to view this content.
Hematological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Haegarda Approved for Pediatric Hereditary Angioedema
FDA Approves Nucala for Hypereosinophilic Syndrome
Factors Contributing to Darbepoetin Responsiveness in CKD
Vadadustat Noninferior to Darbepoetin in CKD
Medical Marijuana Tied to Fewer Admissions in Sickle Cell Disease
Label Mix-Up Prompts Recall of IV Amiodarone, Tranexamic Acid
FDA Wants More Data on Gene Therapy for Hemophilia A
Xyntha Approved for Routine Prophylaxis in Hemophilia A
Ferric Citrate May Improve Iron Parameters Better Than Ferrous Sulfate in CKD
Nasal Sprays Containing Desmopressin Recalled Due to Superpotency
First CAR T-Cell Therapy Approved for Mantle Cell Lymphoma
Inolimomab BLA Submitted for Graft Versus Host Disease
Caplacizumab Safe, Effective for Acquired Thrombotic Thrombocytopenic Purpura
Limited ESA Use in COVID-19 Patients Recommended
Tazverik Granted Accelerated Approval for Follicular Lymphoma
Blood Donors Will Get Results of Coronavirus Antibody Test, Red Cross Says
Biosimilar Nyvepria Gets FDA Approval
FDA Grants Orphan Drug Status to Mitapivat for Thalassemia
